| Followers | 48 |
| Posts | 23462 |
| Boards Moderated | 0 |
| Alias Born | 09/16/2012 |
Friday, August 26, 2016 12:27:15 PM
Recent MNKD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2026 01:30:02 AM
- MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026 • GlobeNewswire Inc. • 03/09/2026 01:05:00 PM
- MannKind Announces Settlement of Convertible Senior Notes • GlobeNewswire Inc. • 03/05/2026 09:30:00 PM
- MannKind to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/04/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:50:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:50:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:50:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 02:50:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 02:50:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 02:50:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 02:50:03 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 01:06:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:03:36 PM
- MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/19/2026 02:00:00 PM
- MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 • GlobeNewswire Inc. • 02/18/2026 02:00:00 PM
- MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D) • GlobeNewswire Inc. • 02/09/2026 11:05:00 AM
- Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration • PR Newswire (US) • 01/29/2026 06:31:00 PM
- Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration • PR Newswire (Canada) • 01/29/2026 06:31:00 PM
- Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets • PR Newswire (US) • 01/26/2026 03:16:00 PM
- Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets • PR Newswire (Canada) • 01/26/2026 03:16:00 PM
- MannKind shares climb after FDA clears revised Afrezza prescribing label • IH Market News • 01/26/2026 02:46:42 PM
- MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy • GlobeNewswire Inc. • 01/26/2026 11:05:00 AM
- Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets • GlobeNewswire Inc. • 01/23/2026 05:56:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2026 01:30:03 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
